Related Experiment Video
Updated: Jul 24, 2026
11:57
Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
9.7K
Edaravone ameliorates compression-induced damage in rat nucleus pulposus cells
Hui Lin1, Xuan Ma1, Bai-Chuan Wang1
1Department of Orthopedic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.
Life Sciences
|September 25, 2017
Summary
Edaravone protects nucleus pulposus cells from compression damage by reducing apoptosis and improving extracellular matrix proteins. This suggests edaravone may treat intervertebral disc degeneration (IDD).
Area of Science:
- Biochemistry
- Cell Biology
- Regenerative Medicine
Background:
- Nucleus pulposus (NP) cells are crucial for intervertebral disc health.
- Compression-induced damage to NP cells contributes to intervertebral disc degeneration (IDD).
- Edaravone, a free radical scavenger, is used for acute ischemic stroke.
Purpose of the Study:
- To investigate the protective effects of edaravone on NP cells under compression.
- To elucidate the underlying mechanisms of edaravone's action in NP cells.
Main Methods:
- Cell viability assessed via MTT assay.
- Apoptosis evaluated using Hoechst 33,258 and Annexin V/PI staining.
- Intracellular reactive oxygen species (ROS), mitochondrial membrane potential (MMP), and calcium levels ([Ca2+]i) measured using fluorescent probes.
- Western blot analysis for apoptosis-related and extracellular matrix proteins (e.g., caspase-3, Bax, Bcl-2, aggrecan, collagen II).
Main Results:
- Edaravone dose-dependently increased NP cell viability under compression.
- Edaravone inhibited compression-induced apoptosis in NP cells.
- Edaravone mitigated ROS overproduction, MMP collapse, and [Ca2+]i overload.
- Edaravone promoted aggrecan and collagen II expression in compressed NP cells.
Conclusions:
- Edaravone effectively ameliorates compression-induced damage in rat nucleus pulposus cells.
- Edaravone's protective mechanisms involve inhibiting apoptosis and preserving extracellular matrix.
- Edaravone shows potential as a novel therapeutic agent for intervertebral disc degeneration (IDD).
